What G63 covers · when clinicians use it
ICD-10 code G63 identifies Polyneuropathy in diseases classified elsewhere in the U.S. ICD-10-CM clinical and billing record set. It sits within the Nervous System chapter (G00–G99), the section that groups related diagnoses so providers, payers, and public-health agencies report them consistently. Clinicians and medical coders apply G63 when an encounter's findings match the Polyneuropathy in diseases classified elsewhere description, attaching it to the patient record so downstream insurance claims, payer audits, quality reporting, and epidemiological surveillance all reference the same standardized diagnosis. The ICD-10-CM is maintained by the Centers for Medicare & Medicaid Services and the CDC's National Center for Health Statistics, with an updated official code set released each U.S. fiscal year — always verify G63 against the current CMS/CDC release and your payer's documentation guidance before final use. This page summarizes documentation context for G63 and is a coding reference, not clinical, diagnostic, or billing advice.
G63 refers to Polyneuropathy in diseases classified elsewhere, a group of conditions involving damage to multiple peripheral nerves. These neuropathies can be inherited, caused by autoimmune inflammation, systemic illness, or toxic exposure, and often lead to functional impairments and chronic discomfort.
Symptoms
- Numbness or tingling in hands and feet – A hallmark of polyneuropathy
- Burning or stabbing pain – Frequently seen in G60 and G61 neuropathies
- Muscle weakness – Progressive in hereditary or inflammatory forms
- Loss of reflexes – Noted in advanced polyneuropathies (G62, G63)
- Difficulty walking or balance issues – Especially in long-standing cases
- Autonomic dysfunction – Including changes in heart rate, sweating, or digestion (often in G64)
- Residual neuropathy symptoms – Persisting after recovery in G65 cases
Diagnosis
Diagnosis of Polyneuropathy in diseases classified elsewhere includes nerve conduction studies, EMG, genetic testing (for hereditary forms), lumbar puncture (in GBS-type G61), lab tests for systemic conditions (e.g., diabetes, B12 deficiency), and MRI in selected cases. Thorough neurological exam is key.
ICD10 Code Usage
ICD10 code G63 is used in neurology, rehabilitation medicine, internal medicine, and primary care. It supports classification of neuropathies for treatment planning, insurance billing, disability assessments, and long-term monitoring of nerve-related dysfunction.
Related Codes
- G60 – Hereditary and idiopathic neuropathy
- G61 – Inflammatory polyneuropathy
- G62 – Other and unspecified polyneuropathies
- G64 – Other disorders of peripheral nervous system
- G65 – Sequelae of inflammatory and toxic polyneuropathies
FAQs
Q1: What is ICD10 code G63?
A: It identifies Polyneuropathy in diseases classified elsewhere, a disorder involving multiple peripheral nerves with symptoms ranging from numbness to motor weakness.
Q2: Are these conditions permanent?
A: Some hereditary and toxic neuropathies are chronic, but inflammatory forms like GBS may be reversible with early treatment.
Q3: What causes polyneuropathy?
A: Causes include genetics, autoimmune disease, diabetes, toxins, nutritional deficiencies, or secondary systemic illnesses.
Q4: What treatments are available?
A: Immunotherapy (for G61), pain management, physiotherapy, assistive devices, and treatment of underlying conditions.
Q5: Who manages these disorders?
A: Neurologists, physiatrists, pain specialists, endocrinologists, and physical therapists.
Conclusion
ICD10 code G63 plays a crucial role in diagnosing and documenting Polyneuropathy in diseases classified elsewhere. Early identification enables timely intervention, management of symptoms, and access to therapies that can improve function and quality of life.